Valuation Unichem Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:02:22 2026-08-07 EDT			5-day change	1st Jan Change
488.20 ^INR	-1.64%		-6.69%	+10.62%

05-22	Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-22	Unichem Laboratories March-quarter consol profit 109.1 million rupees	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	21,776	18,330	20,351	34,393	48,777	20,682
Change	-	-15.83%	11.02%	69%	41.82%	-57.6%
Enterprise Value (EV) ¹	19,829	18,094	21,638	35,346	52,479	22,788
Change	-	-8.75%	19.59%	63.35%	48.47%	-56.58%
P/E	63.4x	55.6x	-10.1x	-48.8x	35.6x	8.19x
PBR	0.85x	0.7x	0.84x	1.46x	1.99x	0.76x
PEG	-	-13.88x	0x	0.7x	-0x	0.1x
Capitalization / Revenue	1.76x	1.44x	1.52x	2.02x	2.31x	0.94x
EV / Revenue	1.61x	1.42x	1.61x	2.07x	2.49x	1.03x
EV / EBITDA	23.6x	24.2x	-45.1x	37.5x	20.4x	12.6x
EV / EBIT	273x	-166x	-13.9x	-272x	37.4x	35.8x
EV / FCF	-9.72x	-5.18x	-29.2x	64.1x	-23.3x	-20.8x
FCF Yield	-10.3%	-19.3%	-3.42%	1.56%	-4.3%	-4.8%
Dividend per Share ²	4	4	-	-	-	-
Rate of return	1.29%	1.54%	-	-	-	-
EPS ²	4.875	4.68	-28.72	-10.01	19.47	35.85
Distribution rate	82%	85.5%	-	-	-	-
Net sales ¹	12,351	12,698	13,430	17,049	21,110	22,018
EBITDA ¹	838.6	747	-480.2	943.7	2,577	1,815
EBIT ¹	72.76	-109	-1,556	-129.9	1,403	635.7
Net income ¹	343.2	330.6	-2,022	-704.7	1,375	2,528
Net Debt ¹	-1,948	-236.2	1,288	952.6	3,702	2,107
Reference price ²	309.30	260.35	289.05	488.50	692.80	293.75
Nbr of stocks (in thousands)	70,406	70,406	70,406	70,406	70,406	70,406
Announcement Date	7/2/21	7/12/22	8/30/23	7/11/24	7/4/25	7/3/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
UNICHEM LABORATORIES LIMITED	-	-	-	-	367M
ELI LILLY AND COMPANY	33.78x	12.37x	24.91x	0.57%	1,062B
JOHNSON & JOHNSON	28.59x	-	-	2.09%	619B
ABBVIE INC.	32.06x	7.3x	15.18x	2.84%	431B
ROCHE HOLDING AG	20.32x	4.82x	11.94x	2.74%	358B
NOVARTIS AG	21.87x	5.66x	14.12x	2.84%	293B
ASTRAZENECA PLC	20.44x	4.22x	11.99x	2.09%	247B
AMGEN INC.	25.38x	6.71x	11.89x	2.49%	219B
NOVO NORDISK A/S	13.28x	4.8x	10.09x	3.83%	200B
GILEAD SCIENCES, INC.	-40.65x	5.84x	32.95x	2.52%	162B
Average	17.23x	6.46x	16.63x	2.44%	359.26B
Weighted average by Cap.	24.43x	8.10x	18.28x	2%